secwatch.observer — SEC 8-K summary
======================================

Issuer:     TransMedics Group, Inc. (TMDX)
CIK:        0001756262
Form:       8-K
Filed at:   2022-06-02T23:59:59+00:00
Accession:  0001193125-22-166255
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

TransMedics shareholders reject say-on-pay and stock incentive plan at 2022 annual meeting
--------------------------------------------------------------------------------

- All eight director nominees elected; Waleed Hassanein received 17.9M for votes.
- Say-on-pay advisory vote failed: 10.4M against vs 7.5M for.
- Amended 2019 stock incentive plan not approved: 10.58M against vs 7.36M for.
- Advisory vote on frequency approved 1 year with 17.9M votes.
- Ratification of PwC as auditor passed with 20.0M for votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756262/000119312522166255/0001193125-22-166255-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756262/000119312522166255/d331128d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-166255

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer